Raymond James Financial Services Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-14,670
Closed -$276K 3224
2023
Q1
$276K Hold
14,670
﹤0.01% 2696
2022
Q4
$234K Buy
+14,670
New +$234K ﹤0.01% 2759
2022
Q2
Sell
-23,611
Closed -$572K 3186
2022
Q1
$572K Buy
+23,611
New +$572K ﹤0.01% 2303
2021
Q3
Sell
-11,234
Closed -$274K 3227
2021
Q2
$274K Buy
11,234
+1,002
+10% +$24.4K ﹤0.01% 2783
2021
Q1
$264K Sell
10,232
-5,533
-35% -$143K ﹤0.01% 2709
2020
Q4
$843K Buy
15,765
+9,146
+138% +$489K ﹤0.01% 1804
2020
Q3
$273K Buy
6,619
+78
+1% +$3.22K ﹤0.01% 2322
2020
Q2
$317K Sell
6,541
-1,657
-20% -$80.3K ﹤0.01% 2196
2020
Q1
$346K Sell
8,198
-3,893
-32% -$164K ﹤0.01% 1761
2019
Q4
$517K Buy
12,091
+3,150
+35% +$135K ﹤0.01% 1960
2019
Q3
$322K Buy
+8,941
New +$322K ﹤0.01% 2198
2018
Q3
Sell
-39,372
Closed -$601K 2775
2018
Q2
$601K Sell
39,372
-496
-1% -$7.57K ﹤0.01% 1752
2018
Q1
$896K Sell
39,868
-10,620
-21% -$239K 0.01% 1372
2017
Q4
$1.52M Buy
50,488
+2,256
+5% +$67.9K 0.01% 1034
2017
Q3
$1.82M Buy
48,232
+2,325
+5% +$87.6K 0.01% 961
2017
Q2
$1.28M Buy
45,907
+8,006
+21% +$223K 0.01% 1110
2017
Q1
$1.3M Sell
37,901
-5,844
-13% -$201K 0.01% 1029
2016
Q4
$1.26M Sell
43,745
-13,761
-24% -$397K 0.01% 993
2016
Q3
$1.83M Sell
57,506
-8,600
-13% -$274K 0.02% 816
2016
Q2
$2.15M Buy
66,106
+16,865
+34% +$547K 0.02% 702
2016
Q1
$1.38M Buy
49,241
+7,605
+18% +$213K 0.02% 773
2015
Q4
$1.48M Buy
41,636
+28,225
+210% +$1.01M 0.02% 762
2015
Q3
$444K Buy
+13,411
New +$444K 0.01% 1104